193 related articles for article (PubMed ID: 4633691)
1. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
Rahman YE; Rosenthal MW; Cerny EA
Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
[TBL] [Abstract][Full Text] [Related]
2. Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen.
Grémy O; Miccoli L; Lelan F; Bohand S; Cherel M; Mougin-Degraef M
Radiat Res; 2018 May; 189(5):477-489. PubMed ID: 29528770
[TBL] [Abstract][Full Text] [Related]
3. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
[No Abstract] [Full Text] [Related]
4. [Metabolism and toxicity of therapeutic chelating agents. 4. Excretion and metabolic degradation of EDTA and DTPA].
Havlícek F; Bohne F; Zorn H
Strahlentherapie; 1968 Nov; 136(5):604-8. PubMed ID: 4974440
[No Abstract] [Full Text] [Related]
5. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
[TBL] [Abstract][Full Text] [Related]
6. Liposomal encapsulated Zn-DTPA for removing intracellular 169Yb.
Blank ML; Cress EA; Byrd BL; Washburn LC; Snyder F
Health Phys; 1980 Dec; 39(6):913-20. PubMed ID: 6782042
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
[TBL] [Abstract][Full Text] [Related]
8. Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.
Rahman YE; Rosenthal MW; Cerny EA; Moretti ES
J Lab Clin Med; 1974 Apr; 83(4):640-7. PubMed ID: 4206355
[No Abstract] [Full Text] [Related]
9. The influence of DTPA on the metabolism of inhaled 239PuF4 in beagles.
McDonald KE; Dilley JV; Sanders CL; Mahaffey JA
Health Phys; 1979 May; 36(5):632-5. PubMed ID: 489316
[No Abstract] [Full Text] [Related]
10. Comparison of the antidotal efficacy of polyamincarboxylic acids (CDTA and DTPA) with time after acute zinc poisoning.
Llobet JM; Colomina MT; Domingo JL; Corbella J
Vet Hum Toxicol; 1989 Feb; 31(1):25-8. PubMed ID: 2496518
[TBL] [Abstract][Full Text] [Related]
11. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats.
Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H
Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998
[TBL] [Abstract][Full Text] [Related]
12. Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.
Phan G; Ramounet-Le Gall B; Manceau J; Fanet M; Benech H; Fritsch P; Fattal E; Deverre JR
Int J Radiat Biol; 2004 Jun; 80(6):413-22. PubMed ID: 15362694
[TBL] [Abstract][Full Text] [Related]
13. [Effect of liposome-encapsulated pentacin on plutonium-239 excretion].
Il'in LA; Ivannikov AT; Altukhova GA; Parfenova IM; Chelysheva TV
Radiobiologiia; 1989; 29(2):197-201. PubMed ID: 2717714
[TBL] [Abstract][Full Text] [Related]
14. Removal of plutonium from mouse liver by glucan and DTPA.
Rosenthal MW; Brown H; Chladek DL; Moretti ES; Russell JJ; Lindenbaum A
Radiat Res; 1973 Jan; 53(1):102-14. PubMed ID: 4568226
[No Abstract] [Full Text] [Related]
15. DTPA-Coated Liposomes as a New Delivery Vehicle for Plutonium Decorporation.
Grémy O; Mougin-Degraef M; Devilliers K; Berdal M; Laroche P; Miccoli L
Radiat Res; 2021 Jan; 195(1):77-92. PubMed ID: 33180911
[TBL] [Abstract][Full Text] [Related]
16. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
Lau EH; Cerny EA; Wright BJ; Rahman YE
J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
[TBL] [Abstract][Full Text] [Related]
17. [Acceleration of the excretion of monomeric 239Pu-citrate from the body as effected by pentacyne encapsulated in liposomes].
Il'in LA; Smirnov AA; Ivannikov AT; Parfenova IM
Vopr Med Khim; 1983; 29(4):109-12. PubMed ID: 6353751
[TBL] [Abstract][Full Text] [Related]
18. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
[TBL] [Abstract][Full Text] [Related]
19. Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal.
Rahman YE; Wright BJ
J Cell Biol; 1975 Apr; 65(1):112-22. PubMed ID: 805148
[TBL] [Abstract][Full Text] [Related]
20. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
Harmuth-Hoene AE
Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
